RELENZA

国: イスラエル

言語: 英語

ソース: Ministry of Health

有効成分:

ZANAMIVIR MICRONIZED

から入手可能:

GLAXO SMITH KLINE (ISRAEL) LTD

ATCコード:

J05AH01

医薬品形態:

POWDER FOR INHALATION

構図:

ZANAMIVIR MICRONIZED 5 MG

投与経路:

INHALATION

処方タイプ:

Required

製:

GLAXO SMITH KLINE AUSTRALIA PTY LTD

治療群:

ZANAMIVIR

治療領域:

ZANAMIVIR

適応症:

Zanamivir is indicated for the treatment of both uncomplicated acute illness due to influenza A and B virus in adults and adolescents (> or = 12 years) who have been symptomatic for no more than 48 hours and pediatric patients 7 years and older who have been symptomatic for no more than 36 hours.

承認日:

2017-03-26